Loading organizations...
Ventis Medical develops HeroVent, an FDA-cleared emergency and transport ventilator. This portable device delivers comprehensive respiratory support, offering invasive and non-invasive modes with volume and pressure control, alongside FiO2 and EtCO2 monitoring. Engineered for rapid, intuitive operation, HeroVent utilizes advanced turbine technology in a rugged, lightweight design, enabling critical medical use in diverse scenarios.
The company’s genesis stems from cardiac surgeon Dr. Glenn W. Laub’s insight into the urgent need for accessible ventilators, inspired by patient distress from a lack of equipment. A Defibtech LLC co-founder, Dr. Laub brought entrepreneurial experience to this venture. He leads with President Karen Laub, a registered nurse, and co-founders Taylor Laub, David Laub, and Steve Jacobson.
Ventis Medical’s product targets emergency medical teams, enabling crucial care in critical situations like EMS, where manual ventilation is challenging. The company aims to empower these teams with innovative respiratory technology, making lifesaving treatment broadly accessible. This commitment addresses limitations in both equipment accessibility and specialized training requirements.
Key people at Ventis.
Ventis has 2 tracked investments across 2 companies. The latest tracked deal is $1.4M Seed Extension in UseCodify in February 2024.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 19, 2024 | UseCodify | $1.4M Seed Extension | — | Another.vc, APEX Ventures, E2MC, High Tech Grunderfonds, OTB Ventures, Seraphim Capital |
| Jan 29, 2024 | Locaboo | $1.3M Seed | Jesse Jeng | — |
Key people at Ventis.